Daria M. Tanska

Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells

Leslie A. Parsels, Meredith A. Morgan, Daria M. Tanska et al. · Molecular Cancer Therapeutics · 2009 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Carl G. Engelke, Leslie A. Parsels, Yushen Qian et al. · Clinical Cancer Research · 2013 · 102 citations

Medicine, Oncology, Pharmacology +14

Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition

Leslie A. Parsels, Yushen Qian, Daria M. Tanska et al. · Clinical Cancer Research · 2011 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17

Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer

Leslie A. Parsels, Carl G. Engelke, Joshua D. Parsels et al. · Molecular Cancer Therapeutics · 2020 · 45 citations · Full text

Medicine, Oncology, Radiation Oncology +13

The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors

Leslie A. Parsels, Joshua D. Parsels, Daria M. Tanska et al. · Cell Cycle · 2018 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17